tiprankstipranks
Dhampur Bio Organics Ltd (IN:DBOL)
:DBOL
India Market
Want to see IN:DBOL full AI Analyst Report?

Dhampur Bio Organics Ltd (DBOL) AI Stock Analysis

0 Followers

Top Page

IN:DBOL

Dhampur Bio Organics Ltd

(DBOL)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
₹126.00
▲(60.24% Upside)
Action:Reiterated
Date:03/31/26
The score is anchored by mixed financials—profitability pressure, negative free cash flow, and rising debt offset moderate growth—while strong technical trend signals and a low P/E valuation meaningfully support the overall outlook.
Positive Factors
Integrated business model
Dhampur’s integrated sugar and bio-energy operations convert cane into multiple revenue streams (sugar, ethanol, co-products), which sustainably diversifies cash generation and smooths margins across cycles. This structural vertical integration supports durability in earnings and resilience to single-product shocks over months.
Negative Factors
Rising leverage
An increasing debt load raises financial risk and reduces flexibility for capital allocation. Over a 2–6 month horizon higher leverage can increase interest cost sensitivity and constrain investment in capacity or working capital, limiting the company’s ability to capitalize on growth or absorb commodity shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Integrated business model
Dhampur’s integrated sugar and bio-energy operations convert cane into multiple revenue streams (sugar, ethanol, co-products), which sustainably diversifies cash generation and smooths margins across cycles. This structural vertical integration supports durability in earnings and resilience to single-product shocks over months.
Read all positive factors

Dhampur Bio Organics Ltd (DBOL) vs. iShares MSCI India ETF (INDA)

Dhampur Bio Organics Ltd Business Overview & Revenue Model

Company Description
Dhampur Bio Organics Limited, an integrated sugarcane processing company, engages in the manufacture and sale of refined and raw sugar, biofuels, biomass based renewable power, and other related products in India. It also offers alcoholic beverage...
How the Company Makes Money
DBOL primarily makes money by selling sugar and allied products produced from sugarcane, supplemented by revenue from bio-energy and other sugarcane-derived by-products. Key revenue streams typically include: (1) Sugar sales: revenue from manufact...

Dhampur Bio Organics Ltd Financial Statement Overview

Summary
Moderate revenue growth and improved gross margin are positives, but the sharply lower net profit margin, rising leverage, and persistently negative free cash flow weigh on overall financial quality.
Income Statement
65
Positive
Balance Sheet
60
Neutral
Cash Flow
55
Neutral
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue20.12B18.62B18.39B24.08B15.54B0.00
Gross Profit4.69B4.76B3.65B5.50B2.20B0.00
EBITDA1.17B1.38B1.59B2.13B1.90B-100.00K
Net Income-500.00K146.90M464.90M1.11B1.02B-100.00K
Balance Sheet
Total Assets16.45B23.98B23.13B20.77B20.01B15.51B
Cash, Cash Equivalents and Short-Term Investments564.30M389.80M293.90M1.04B229.80M138.70M
Total Debt5.62B11.62B10.57B8.10B8.35B4.03B
Total Liabilities6.83B13.86B13.01B10.89B11.23B7.76B
Stockholders Equity9.62B10.12B10.11B9.89B8.77B7.75B
Cash Flow
Free Cash Flow6.69B-161.70M-2.72B1.45B-4.08B-100.00K
Operating Cash Flow6.89B1.30B-1.01B3.55B-2.46B-100.00K
Investing Cash Flow-178.20M-1.46B-1.66B-1.96B-1.38B0.00
Financing Cash Flow-6.52B187.90M1.70B-781.20M3.94B100.00K

Dhampur Bio Organics Ltd Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price78.63
Price Trends
50DMA
111.02
Negative
100DMA
100.51
Positive
200DMA
90.45
Positive
Market Momentum
MACD
-1.07
Positive
RSI
37.87
Neutral
STOCH
17.61
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DBOL, the sentiment is Neutral. The current price of 78.63 is below the 20-day moving average (MA) of 116.70, below the 50-day MA of 111.02, and below the 200-day MA of 90.45, indicating a neutral trend. The MACD of -1.07 indicates Positive momentum. The RSI at 37.87 is Neutral, neither overbought nor oversold. The STOCH value of 17.61 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:DBOL.

Dhampur Bio Organics Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
₹48.75B96.951.01%13.59%0.52%
69
Neutral
₹7.16B7.781.63%9.33%154.84%
63
Neutral
₹255.65B19.6617.28%-14.64%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
₹110.52B24.531.92%9.06%9.97%
58
Neutral
₹852.01M25.72-1.79%-129.07%
46
Neutral
₹2.76B137.710.46%-16.20%-83.32%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:DBOL
Dhampur Bio Organics Ltd
107.90
31.27
40.81%
IN:AWL
Adani Wilmar Limited
196.70
-63.65
-24.45%
IN:GODREJAGRO
Godrej Agrovet Limited
574.55
-156.09
-21.36%
IN:KSCL
Kaveri Seed Co. Ltd.
947.75
-439.05
-31.66%
IN:SAKUMA
Sakuma Exports Limited
1.76
-1.27
-41.91%
IN:UMAEXPORTS
Uma Exports Ltd.
25.20
-48.37
-65.75%

Dhampur Bio Organics Ltd Corporate Events

Dhampur Bio Organics to Sell Meerganj Sugar Unit, Launch JV in Functional Foods
Apr 20, 2026
Dhampur Bio Organics Ltd’s board has approved the transfer of its Meerganj sugar factory in Bareilly, Uttar Pradesh, as a going concern on a slump-sale basis to Forever Global Enterprises, signaling a strategic reshaping of its manufacturing...
Dhampur Bio Organics to Sell Meerganj Sugar Unit, Launch JV in Functional Foods
Apr 20, 2026
Dhampur Bio Organics Ltd. has approved the transfer of its Meerganj sugar factory in Bareilly, Uttar Pradesh, as a going concern on a slump sale basis to Forever Global Enterprises Ltd., marking a significant portfolio reshaping of its core sugar ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 31, 2026